Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides

Neuroendocrinology

Volumn 65, Issue 3, 1997, Pages 189-199

  Reul, Johannes M H M ^a   Probst, J Christopher ^a   Skutella, Thomas ^a   Hirschmann, Martin ^a   Stec, Ingemar S M ^a   Montkowski, Alexandra ^a   Landgraf, Rainer ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Adrenal steroid receptors; Adrenal steroids; Antisense; Anxiety; Corticotropin; Hippocampus; Stress

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CORTICOSTERONE; CORTICOTROPIN; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; FEMALE; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; OLIGONUCLEOTIDES, ANTISENSE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; RECEPTORS, STEROID; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0031037209     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127272     Document Type: Article

References (58)

1. Rail JMHM, Dc Kloct ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation, Endocrinology 1985;117:2505-2512.
2. Reul JMHM, Dc Kloct ER, Van Sluijs FJ, Rijnberk A, Rothuizen J: Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary, Endocrinology 1990:127:907-915.
3. Me Ewen BS, Dc Kloet ER, Rostcne W: Adrenal steroid receptors and actions in the nervous system, Physiol Rev 1986:66:1121-1188
4. Gerlach JL., Me Ewcn BS: Rat brain binds adrenal steroid hormone: Radioautography of hippocampus with corticosterone, Science 1972; 175:1133-1136.
5. Reul JMHM, Dc Kloet ER: Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis, J Steroid Biochcm 1986:24:269-272.
6. Van Eekelen JAM, Jiang W, De Kloct ER, Bohn MC: Distribution of the mincralocorti-coid and the glucocorticoid receptor mRNAs in the rat hippocampus, J Neurosci Res 1988:21: 88-94.
7. Herman JP, Patel PD, Akil H, Watson SJ: Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat, Mol Endocrinol 1989:3:1886-1894.
8. Fuse K, Wilstrdm A-C, Okret S, Agnati LF, Harfstrand A, Yu Z-Y, Granholm L, Zoli M, Vale W, Gustafsson JA: Mapping of glucocorticoid receptor niRNA in the male rat brain by in situ hybridization, Endocrinology 1985:117: 1803-1812.
9. Aronsson M, Fuxe K, Dong Y: Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization, Proc Natl Acad Sci USA 1988;85:9331-9335.
10. De Kloct ER, Reul JMHM: Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems, Psychoneuroendocrinology 1987; 12:83-105.
11. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N: Regulation of ACTH secretion: Variations on a theme of B, Recent Prog Horrn Res 1987:43:113-173.
12. De Kloct ER: Brain corticosteroid receptor balance and homeostatic control, Front Neuroen-docrinol 1991; 12:95-164.
13. Korte SM, De Boer SF, De Kloet ER, Bohus B: Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze, Psychoneuroendocrinology 1995:20:385-394.
14. Oitzl MS, De Kloet ER: Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning, Behav Neurosci 1992:106:62-61.
15. Jcffervs D, Funder JW: Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress, Endocrinology 1987:121:1006-1109.
16. Philibert D, Deraedt R, Tourncminc C, Mary I, Tculsch G: RU-38486, a potent anliprogcstcr-one (abstract), Program of the 6th International Congress of Hormonal Steroids, Jerusalem 1982, p 204.
17. Spitz IM, Bardin CW: Mifepristone (RU-486)-A modulator of progestin and glucocorticoid action, N Engl J Med 1993:329:404-412.
18. Sutanto W, Dc Kloet ER: Z.K-91587: A novel synthetic antimincralocorticoid displays high affinity for corticosterone (type I) receptors in the rat hippocampus, Life Sci 1988:43:1537-1543.
19. Ratka A, Sutanto W, Blocmcrs M, Dc Kloct ER: On the role of brain mineralocorticoid (typc-1) and glucocorticoid (type-11) receptors in neuroendocrine regulation, Neuroendocrinology 1989:50:117-123.
20. Pavlidcs C, Watanabe Y, Magarinos AM, McEwen BS: Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation, Neuroscience 1995; 68:387-394.
21. Skutella T, Probst JC, Engclmann M, Wotjak CT, Landgraf R, Jirikowski GF: Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats, J Ncurocndocrinol 1994:6:121-125.
22. Landgraf R, Gcrstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, Engclmann M: VI vasopressin receptor antisensc oligodc-oxynuclcotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats, J Neurosci 1995;15:4250-4258.
23. Wahlestedt C: Antisense oligonucleotide strategics in ncuropharmacology, Trends Pharmacol Sci 1994;15:42-46.
24. Simons SS Jr, Pratt WB: Glucocorticoid receptor thiols and steroid-binding activity, Methods Enzymol 1995;251:406-422.
25. Luttgc WG, Davda MM, Rupp ME, Kang CG: High affinity binding and regulatory actions of dcxamcthasone-typc I receptor complexes in mouse brain, Endocrinology 1989:125:1194-1203.
26. Spencer RL, Young EA, Choo PH, Me Ewcn BS: Adrenal steroid typc-1 and type-11 receptor binding-Estimates of in vivo receptor number, occupancy, and activation with varying level of steroid, Brain Res 1990:514:37-48.
27. Lowry OIL, Rosebrough NJ, Farr AL, Randall NJ: Protein measurement with the Folin phenol reagent, J Biol Chent 1951:193:265-275.
28. Skutella T, Montkowski A, Stohr T, Probst JC, Landgraf R, Holsboer F, Jirikowski GF: Corticotropin-releasing hormone antisensc oiigode-oxynucleotide treatment attenuates social defeat-induced anxiety in rats, Cell Mol Neuro-biol 1994;14:579-588.
29. Reul JMHM, Stec I, Söder M, Holsboer F: Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hvpothalamic-pituitary-adrenocortical system, Endocrinology 1993; 133:312-320.
30. Reul JMHM, Stec I, Wicgcrs GJ, Labour MS, Linthorst ACE, Arzt E, Holsboer F: Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats, J Clin Invesi 1994:93:2600-2607.
31. Reul JMHM, Labour MS, Grigoriadis DE, Dc Souza EB, Holsboer F: Hypothalamic-pitu-itary-adrcnocortical axis changes in the rat after long-term treatment with the reversible monoamineoxidase-A inhibitor moclobemide, Neurocndocrinologv 1994;60:509-519.
32. Heinrichs SC, Mcrlo-Pich E, Miczek KA, Britton KT, Koob GF: Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action, Brain Res 1992:581:190-197.
33. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2, San Diego, Academic Press, 1986.
34. Reul JMHM, Van den Bosch FR, Dc Kloet ER: Differential response of type I and type II corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity, Neuroendocrinology 1987:45:407-412.
35. Weiss J, Me Ewen BS, Silva M, Kalkut M: Pituitary-adrenal alterations and fear responding, Am J Physiol 1970:218:864-868.
36. File SE, Velluci SV, Wcndlandt S: Corticosterone-An anxiogenic or an anxiolytic agent? J Pharm Pharmacol 1979:31:300-305.
37. Herman JP, Schafer MKH, Young EA, Thompson R, Douglas J, Akil H, Watson SJ: Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pitu-itary-adrenocortical axis, J Neurosci 1989:9: 3072-3082.
38. Arriza JL, Simerly RB, Swanson LW, Evans RM: The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response, Neuron 1988;1:887-900.
39. Evans RM: The steroid and thyroid hormone receptor supcrfamily, Science 1988:240:889-895.
40. Bcato M: Gene regulation by steroid hormones, Cell 1989:56:335-344.
41. Truss M, Beato M: Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors, Endocr Rev 1993:14: 459-479.
42. Trapp T, Rupprecht R, Castrcn M, Reul JMHM, Holsboer F: Hetcrodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS, Neuron 1994:13:1457-1462.
43. Bradbury MJ, Akana SF, Dallman MF: Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-piluitary-adrenal axis during the diurnal trough and the peak-Evidence for a nonadditive effect of combined receptor occupation, Endocrinology 1994;134:1286-1296.
44. Linthorst ACE, Flachskamm C, Holsbocr F, Reul JMHM: Local administration of recombinant human interleukin-1-bcta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrcnocorti-cal axis activity, and body temperature, Endocrinology 1994:135:520-532.
45. Jasper MS, Engcland WC: Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats, Neuroendocrinology 1994;59:97-109.
46. Korte SM, Bouws GAM, Bohus B: Central actions of corticotropin-releasing homtone on behavioral neuroendocrine, and cardiovascular regulation: Brain corticoid receptor involvement, Horm Behav 1993;27:167-183.
47. Stumpf WE, Sar M: Steroid hormone target cells in the cxtrahypothalamic brain stem and cervical spinal cort: Neuroendocrine significance, J Steroid Biochenr 1979:11:801-807.
48. Kleitman N, Holzwarth MA: Catccholaminer-gic innervation of the rat adrenal cortex, Cell Tissue Res 1985;241:139-147.
49. Bornstcin SR, Ehrhart-Bornstcin M, Scher-baum WA, Pfeiffer EF, Holst JJ: Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner, Endocrinology 1990:127: 900-906.
50. Robinson PM, Perry RA, Hardy KJ, Coghlan JP, Scoggins BA: The innervation of the adrenal cortex in the sheep, Ovis oris, J Anal 1977; 124:117-129.
51. Walker SW, Lightly ERT, Clyne C, Williams BC, Bird 1M: Adrenergic and cholinergic regulation of cortisol secretion from the zona fasciculate/reticularis of bovine adrenal cortex, Endocr Res 1991:17:237-265.
52. Hadjian AJ, Ventre R, Chambaz EM: Cholinergic muscarinic receptors in bovine adrenal cortex, Biochcm Biophys Res Commun 1981; 98:892-900.
53. Benyamina M, Leboulenger F, Lirhmann I, Delaruc C, Feuilloley M, Vaudry H: Acetylcholine stimulates steroidogenesis in isolated frog adrenal gland through muscarinic receptors: Evidence for a desensitization mechanism, J Endocrinol 1987; 113:339-348.
54. Holzwarth MA: The distribution of vasoactive intestinal peptide in the rat adrenal cortex and medulla, J Aulon Ncrv Syst 1984; 11:269-283.
55. Bloom SR, Edwards AV, Jones CT: Adrenal cortical responses to vasoactive intestinal peptide in conscious hypophysectomized calves, J Physiol (Lond) 1987:391:441-450.
56. Bloom SR, Edwards AV, Jones CT: Adrenal responses to caleitonin gene-related peptide in conscious hypophysectomized calves, J Physiol (Lond) 1989;409:29-41.
57. Kondo I: Immunohistochemical analysis of the localization of neuropeptides in the adrenal gland, Arch Histol Jpn 1985:48:453-481.
58. Malendowicz LK, Lcsniewska B, Miskowiak B: Neuropeptide Y inhibits corticosterone secretion by isolated rat adrenocortical cells, Expe-rientia' 1990:46:721-722.